161 related articles for article (PubMed ID: 23760614)
21. Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan.
Ogata K; Mochimaru Y; Kasai N; Sei K; Kawahara N; Ogata M; Yamamoto Y
Br J Haematol; 2024 May; 204(5):1856-1861. PubMed ID: 38590011
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Utility of Bone Marrow Morphology and Ancillary Studies in Pediatric Patients Under Surveillance for Myelodysplastic Syndrome.
Chisholm KM; Xu M; Davis B; Ogi A; Pacheco MC; Geddis AE; Tsuchiya KD; Rutledge JC
Am J Clin Pathol; 2018 Apr; 149(6):499-513. PubMed ID: 29659673
[TBL] [Abstract][Full Text] [Related]
23. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
24. Hypocellular myelodysplastic syndromes (MDS): new proposals.
Tuzuner N; Cox C; Rowe JM; Watrous D; Bennett JM
Br J Haematol; 1995 Nov; 91(3):612-7. PubMed ID: 8555063
[TBL] [Abstract][Full Text] [Related]
25. [Progress of cytogenetic detection in myelodysplastic syndromes].
Zhou QB; Hu XM; Liu -; Ma R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1536-40. PubMed ID: 22169320
[TBL] [Abstract][Full Text] [Related]
26. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.
Ou Y; Yang Y; Yu H; Zhang X; Liu M; Wu Y
Int J Lab Hematol; 2021 Oct; 43(5):1062-1069. PubMed ID: 33650312
[TBL] [Abstract][Full Text] [Related]
28. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
[TBL] [Abstract][Full Text] [Related]
29. Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.
Stevens-Kroef MJ; Olde Weghuis D; ElIdrissi-Zaynoun N; van der Reijden B; Cremers EMP; Alhan C; Westers TM; Visser-Wisselaar HA; Chitu DA; Cunha SM; Vellenga E; Klein SK; Wijermans P; de Greef GE; Schaafsma MR; Muus P; Ossenkoppele GJ; van de Loosdrecht AA; Jansen JH
Genes Chromosomes Cancer; 2017 Jul; 56(7):524-534. PubMed ID: 28236351
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
31. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
32. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).
Yao CY; Hou HA; Lin TY; Lin CC; Chou WC; Tseng MH; Chiang YC; Liu MC; Liu CW; Kuo YY; Wu SJ; Liao XW; Lin CT; Ko BS; Chen CY; Hsu SC; Li CC; Huang SY; Yao M; Tang JL; Tsay W; Liu CY; Tien HF
Oncotarget; 2016 Sep; 7(39):63177-63188. PubMed ID: 27527853
[TBL] [Abstract][Full Text] [Related]
33. [Molecular biology in myelodysplastic syndromes and acute myeloid leukemias "smoldering"].
Martinelli G; Sartor C; Papayannidis C; Iacobucci I; Paolini S; Clissa C; Ottaviani E; Finelli C
Recenti Prog Med; 2014 Mar; 105(3):118-22. PubMed ID: 24675454
[TBL] [Abstract][Full Text] [Related]
34. [Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification].
Schmitt-Graeff AH; Müller MJ; Fisch P
Pathologe; 2013 Feb; 34(1):45-55. PubMed ID: 23322304
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
36. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
37. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.
O'Keefe CL; Tiu R; Gondek LP; Powers J; Theil KS; Kalaycio M; Lichtin A; Sekeres MA; Maciejewski JP
Exp Hematol; 2007 Feb; 35(2):240-51. PubMed ID: 17258073
[TBL] [Abstract][Full Text] [Related]
38. [Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes].
Werner M; Maschek HJ; Kaloutsi V; Buhr T; Kausche F; Delventhal S; Georgii A
Verh Dtsch Ges Pathol; 1990; 74():139-43. PubMed ID: 1708572
[TBL] [Abstract][Full Text] [Related]
39. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
[TBL] [Abstract][Full Text] [Related]
40. Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.
Verburgh E; Achten R; Maes B; Hagemeijer A; Boogaerts M; De Wolf-Peeters C; Verhoef G
J Clin Oncol; 2003 Jan; 21(2):273-82. PubMed ID: 12525519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
